메뉴 건너뛰기




Volumn 67, Issue 6, 2010, Pages 715-725

Clinical progression in Parkinson disease and the neurobiology of axons

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

EID: 77952926102     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21995     Document Type: Review
Times cited : (747)

References (80)
  • 1
    • 0025169590 scopus 로고
    • Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
    • Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
    • (1990) Science , vol.249 , pp. 1436-1438
    • Bergman, H.1    Wichmann, T.2    DeLong, M.R.3
  • 2
    • 0028796071 scopus 로고
    • Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation
    • Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
    • (1995) Lancet , vol.345 , pp. 91-95
    • Limousin, P.1    Pollak, P.2    Benazzouz, A.3
  • 3
    • 0032491507 scopus 로고    scopus 로고
    • Experimental therapeutics of neurodegenerative disorders: Unmet needs
    • Shoulson I. Experimental therapeutics of neurodegenerative disorders: unmet needs. Science 1998;282:1072-1074.
    • (1998) Science , vol.282 , pp. 1072-1074
    • Shoulson, I.1
  • 4
    • 58349122472 scopus 로고    scopus 로고
    • Why have we failed to achieve neuroprotection in Parkinson's disease?
    • Olanow CW, Kieburtz K, Schapira AH. Why have we failed to achieve neuroprotection in Parkinson's disease? Ann Neurol 2008;64(suppl 2):S101-S110.
    • (2008) Ann Neurol , vol.64 , Issue.SUPPL. 2
    • Olanow, C.W.1    Kieburtz, K.2    Schapira, A.H.3
  • 6
    • 67651160657 scopus 로고    scopus 로고
    • Neuroprotection trials in Parkinson's disease: Systematic review
    • Hart RG, Pearce LA, Ravina BM, et al. Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord 2009;24:647-654.
    • (2009) Mov Disord , vol.24 , pp. 647-654
    • Hart, R.G.1    Pearce, L.A.2    Ravina, B.M.3
  • 7
    • 0034671450 scopus 로고    scopus 로고
    • Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease
    • Eberhardt O, Coelln RV, Kugler S, et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2000;20:9126-9134.
    • (2000) J Neurosci , vol.20 , pp. 9126-9134
    • Eberhardt, O.1    Coelln, R.V.2    Kugler, S.3
  • 8
    • 10744223673 scopus 로고    scopus 로고
    • Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease
    • Hayley S, Crocker SJ, Smith PD, et al. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci 2004;24:2045-2053.
    • (2004) J Neurosci , vol.24 , pp. 2045-2053
    • Hayley, S.1    Crocker, S.J.2    Smith, P.D.3
  • 9
    • 38549134304 scopus 로고    scopus 로고
    • Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo
    • Chen X, Rzhetskaya M, Kareva T, et al. Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo. J Neurosci 2008;28:672-680.
    • (2008) J Neurosci , vol.28 , pp. 672-680
    • Chen, X.1    Rzhetskaya, M.2    Kareva, T.3
  • 10
    • 56749158302 scopus 로고    scopus 로고
    • JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration
    • Ries V, Silva RM, Oo TF, et al. JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration. J Neurochem 2008;107:1578-1588.
    • (2008) J Neurochem , vol.107 , pp. 1578-1588
    • Ries, V.1    Silva, R.M.2    Oo, T.F.3
  • 11
    • 0034652278 scopus 로고    scopus 로고
    • Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases
    • Finn JT, Weil M, Archer F, et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 2000; 20:1333-1341.
    • (2000) J Neurosci , vol.20 , pp. 1333-1341
    • Finn, J.T.1    Weil, M.2    Archer, F.3
  • 12
    • 0037012844 scopus 로고    scopus 로고
    • Axonal self-destruction and neurodegeneration
    • Raff MC, Whitmore AV, Finn JT. Axonal self-destruction and neurodegeneration. Science 2002;296:868-871.
    • (2002) Science , vol.296 , pp. 868-871
    • Raff, M.C.1    Whitmore, A.V.2    Finn, J.T.3
  • 13
    • 27644591304 scopus 로고    scopus 로고
    • Axon degeneration mechanisms: Commonality amid diversity
    • Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 2005;6:889-898.
    • (2005) Nat Rev Neurosci , vol.6 , pp. 889-898
    • Coleman, M.1
  • 14
    • 0037333666 scopus 로고    scopus 로고
    • Staging of brain pathology related to sporadic Parkinson's disease
    • Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24:197-211.
    • (2003) Neurobiol Aging , vol.24 , pp. 197-211
    • Braak, H.1    Del Tredici, K.2    Rub, U.3
  • 15
    • 57749095477 scopus 로고    scopus 로고
    • A critical evaluation of the Braak staging scheme for Parkinson's disease
    • Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008;64:485-491.
    • (2008) Ann Neurol , vol.64 , pp. 485-491
    • Burke, R.E.1    Dauer, W.T.2    Vonsattel, J.P.3
  • 16
    • 68749116710 scopus 로고    scopus 로고
    • A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders
    • Jellinger KA. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 2009;1792:730-740.
    • (2009) Biochim Biophys Acta , vol.1792 , pp. 730-740
    • Jellinger, K.A.1
  • 17
    • 61949220753 scopus 로고    scopus 로고
    • The Parkinson chimera
    • Lees AJ. The Parkinson chimera. Neurology 2009;72:S2-S11.
    • (2009) Neurology , vol.72
    • Lees, A.J.1
  • 18
    • 0000595601 scopus 로고
    • Biochemistry of neurotransmitters in Parkinson's disease
    • Marsden CD, Fahn S, eds. London, UK: Butterworths
    • Agid Y, Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders 2. London, UK: Butterworths, 1987:166-230.
    • (1987) Movement Disorders 2 , pp. 166-230
    • Agid, Y.1    Agid, F.2    Ruberg, M.3
  • 19
    • 0025232430 scopus 로고
    • Parkinson's disease
    • Marsden CD. Parkinson's disease. Lancet 1990;335:948-952.
    • (1990) Lancet , vol.335 , pp. 948-952
    • Marsden, C.D.1
  • 21
    • 0032497504 scopus 로고    scopus 로고
    • Parkinson's disease First of two parts
    • Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053.
    • (1998) N Engl J Med , vol.339 , pp. 1044-1053
    • Lang, A.E.1    Lozano, A.M.2
  • 22
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909.
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 23
    • 0025954066 scopus 로고
    • Ageing and Parkinson's disease: Substantia nigra regional selectivity
    • Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
    • (1991) Brain , vol.114 , pp. 2283-2301
    • Fearnley, J.M.1    Lees, A.J.2
  • 24
    • 0342981758 scopus 로고    scopus 로고
    • Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts
    • DOI 10.1016/S0022-510X(97)00100-7, PII S0022510X97001007
    • Ma SY, Roytta M, Rinne JO, et al. Correlation between neuro-morphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts. J Neurol Sci 1997;151:83-87. (Pubitemid 27398014)
    • (1997) Journal of the Neurological Sciences , vol.151 , Issue.1 , pp. 83-87
    • Ma, S.Y.1    Roytta, M.2    Rinne, J.O.3    Collan, Y.4    Rinne, U.K.5
  • 25
    • 33645749795 scopus 로고    scopus 로고
    • Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra
    • Greffard S, Verny M, Bonnet AM, et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 2006;63:584-588.
    • (2006) Arch Neurol , vol.63 , pp. 584-588
    • Greffard, S.1    Verny, M.2    Bonnet, A.M.3
  • 26
    • 0015745743 scopus 로고
    • Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations
    • Bernheimer H, Birkmayer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-455.
    • (1973) J Neurol Sci , vol.20 , pp. 415-455
    • Bernheimer, H.1    Birkmayer, W.2    Hornykiewicz, O.3
  • 27
    • 0017082987 scopus 로고
    • Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis
    • Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976;38:277-301.
    • (1976) J Neural Transm , vol.38 , pp. 277-301
    • Riederer, P.1    Wuketich, S.2
  • 29
    • 0023874410 scopus 로고
    • Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications
    • Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880. (Pubitemid 18090271)
    • (1988) New England Journal of Medicine , vol.318 , Issue.14 , pp. 876-880
    • Kish, S.J.1    Shannak, K.2    Hornykiewicz, O.3
  • 30
    • 41149129792 scopus 로고    scopus 로고
    • Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
    • Beach TG, Adler CH, Sue LI, et al. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease. Acta Neuropathol 2008;115:445-451.
    • (2008) Acta Neuropathol , vol.115 , pp. 445-451
    • Beach, T.G.1    Adler, C.H.2    Sue, L.I.3
  • 32
    • 18844471416 scopus 로고    scopus 로고
    • In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
    • Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000;47:493-503.
    • (2000) Ann Neurol , vol.47 , pp. 493-503
    • Lee, C.S.1    Samii, A.2    Sossi, V.3
  • 33
    • 0025964041 scopus 로고
    • The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method
    • Pakkenberg B, Moller A, Gundersen HJ, et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J Neurol Neurosurg Psychiatry 1991;54:30-33.
    • (1991) J Neurol Neurosurg Psychiatry , vol.54 , pp. 30-33
    • Pakkenberg, B.1    Moller, A.2    Gundersen, H.J.3
  • 34
    • 79251475537 scopus 로고    scopus 로고
    • The status of dopaminergic putaminal innervation in Parkinson's disease as a function of disease duration: Relevance to trophic factor therapy
    • Presentation 326.9
    • Dodiya HB, Chu Y, Beach TG, et al. The status of dopaminergic putaminal innervation in Parkinson's disease as a function of disease duration: relevance to trophic factor therapy. Abstr Soc Neurosci 2009, Presentation 326.9.
    • (2009) Abstr Soc Neurosci
    • Dodiya, H.B.1    Chu, Y.2    Beach, T.G.3
  • 35
    • 22244442489 scopus 로고    scopus 로고
    • The biochemistry of Parkinson's disease
    • Cookson MR. The biochemistry of Parkinson's disease. Annu Rev Biochem 2005;74:29-52.
    • (2005) Annu Rev Biochem , vol.74 , pp. 29-52
    • Cookson, M.R.1
  • 37
    • 0033538002 scopus 로고    scopus 로고
    • Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry
    • DOI 10.1016/S0304-3940(99)00208-6, PII S0304394099002086
    • Braak H, Sandmann-Keil D, Gai W, et al. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 1999;265:67-69. (Pubitemid 29210200)
    • (1999) Neuroscience Letters , vol.265 , Issue.1 , pp. 67-69
    • Braak, H.1    Sandmann-Keil, D.2    Gai, W.3    Braak, E.4
  • 38
    • 0033539664 scopus 로고    scopus 로고
    • Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein
    • Galvin JE, Uryu K, Lee VM, et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A 1999;96: 13450-13455.
    • Proc Natl Acad Sci U S A 1999 , vol.96 , pp. 13450-13455
    • Galvin, J.E.1    Uryu, K.2    Lee, V.M.3
  • 39
    • 0036322266 scopus 로고    scopus 로고
    • Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
    • Duda JE, Giasson BI, Mabon ME, et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002;52:205-210.
    • (2002) Ann Neurol , vol.52 , pp. 205-210
    • Duda, J.E.1    Giasson, B.I.2    Mabon, M.E.3
  • 40
    • 33846997878 scopus 로고    scopus 로고
    • Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with lewy bodies
    • DOI 10.1523/JNEUROSCI.4564-06.2007
    • Kramer ML, Schulz-Schaeffer WJ. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007;27:1405-1410. (Pubitemid 46255421)
    • (2007) Journal of Neuroscience , vol.27 , Issue.6 , pp. 1405-1410
    • Kramer, M.L.1    Schulz-Schaeffer, W.J.2
  • 41
    • 39749123263 scopus 로고    scopus 로고
    • Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
    • DOI 10.1093/brain/awm302
    • Orimo S, Uchihara T, Nakamura A, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008;131:642-650. (Pubitemid 351294710)
    • (2008) Brain , vol.131 , Issue.3 , pp. 642-650
    • Orimo, S.1    Uchihara, T.2    Nakamura, A.3    Mori, F.4    Kakita, A.5    Wakabayashi, K.6    Takahashi, H.7
  • 42
    • 77953395313 scopus 로고    scopus 로고
    • Leucine-rich repeat kinase 2 mutations and Parkinson's disease: Three questions
    • Greggio E, Cookson MR. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 2009;1:e00002.
    • (2009) ASN Neuro , vol.1
    • Greggio, E.1    Cookson, M.R.2
  • 43
    • 67649813448 scopus 로고    scopus 로고
    • Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease
    • Li Y, Liu W, Oo TF, et al. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 2009;12:826-828.
    • (2009) Nat Neurosci , vol.12 , pp. 826-828
    • Li, Y.1    Liu, W.2    Oo, T.F.3
  • 44
    • 33751256567 scopus 로고    scopus 로고
    • The familial Parkinsonism gene LRRK2 regulates neurite process morphology
    • MacLeod D, Dowman J, Hammond R, et al. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006;52:587-593.
    • (2006) Neuron , vol.52 , pp. 587-593
    • MacLeod, D.1    Dowman, J.2    Hammond, R.3
  • 45
    • 39549117093 scopus 로고    scopus 로고
    • Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
    • Plowey ED, Cherra SJ III, Liu YJ, et al. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 2008;105:1048-1056.
    • (2008) J Neurochem , vol.105 , pp. 1048-1056
    • Plowey, E.D.1    Cherra III, S.J.2    Liu, Y.J.3
  • 46
    • 70449377127 scopus 로고    scopus 로고
    • Phosphorylation of ezrin/ radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis
    • Parisiadou L, Xie C, Cho HJ, et al. Phosphorylation of ezrin/ radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 2009;29:13971-13980.
    • (2009) J Neurosci , vol.29 , pp. 13971-13980
    • Parisiadou, L.1    Xie, C.2    Cho, H.J.3
  • 47
    • 34447118788 scopus 로고    scopus 로고
    • LRRK2 phosphorylates moesin at threonine-558: Characterization of how Parkinson's disease mutants affect kinase activity
    • Jaleel M, Nichols RJ, Deak M, et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007;405:307-317.
    • (2007) Biochem J , vol.405 , pp. 307-317
    • Jaleel, M.1    Nichols, R.J.2    Deak, M.3
  • 48
    • 0032547839 scopus 로고    scopus 로고
    • Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons
    • Paglini G, Kunda P, Quiroga S, et al. Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol 1998;143:443-455.
    • (1998) J Cell Biol , vol.143 , pp. 443-455
    • Paglini, G.1    Kunda, P.2    Quiroga, S.3
  • 49
    • 0031682676 scopus 로고    scopus 로고
    • Biochemical aspects of Parkinson's disease
    • Hornykiewicz O. Biochemical aspects of Parkinson's disease. Neurology 1998;51:S2-S9.
    • (1998) Neurology , vol.51
    • Hornykiewicz, O.1
  • 50
    • 0036774951 scopus 로고    scopus 로고
    • Axon pathology in neurological disease: A neglected therapeutic target
    • Coleman MP, Perry VH. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 2002;25:532-537.
    • (2002) Trends Neurosci , vol.25 , pp. 532-537
    • Coleman, M.P.1    Perry, V.H.2
  • 51
    • 0024373441 scopus 로고
    • Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve
    • Lunn ER, Perry VH, Brown MC, et al. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1989;1:27-33.
    • (1989) Eur J Neurosci , vol.1 , pp. 27-33
    • Lunn, E.R.1    Perry, V.H.2    Brown, M.C.3
  • 52
    • 0034633627 scopus 로고    scopus 로고
    • A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse
    • Conforti L, Tarlton A, Mack TG, et al. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 2000;97:11377-11382.
    • Proc Natl Acad Sci U S A 2000 , vol.97 , pp. 11377-11382
    • Conforti, L.1    Tarlton, A.2    Mack, T.G.3
  • 53
    • 0035195636 scopus 로고    scopus 로고
    • Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
    • Mack TG, Reiner M, Beirowski B, et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001;4:1199-1206.
    • (2001) Nat Neurosci , vol.4 , pp. 1199-1206
    • Mack, T.G.1    Reiner, M.2    Beirowski, B.3
  • 54
    • 0027956623 scopus 로고
    • Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis)
    • Deckwerth TL, Johnson EM Jr. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev Biol 1994;165:63-72.
    • (1994) Dev Biol , vol.165 , pp. 63-72
    • Deckwerth, T.L.1    Johnson Jr., E.M.2
  • 55
    • 0034747230 scopus 로고    scopus 로고
    • s protein protects against axonal degeneration: A model of gene therapy for peripheral neuropathy
    • DOI 10.1002/ana.10039
    • Wang MS, Fang G, Culver DG, et al. The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy. Ann Neurol 2001;50:773-779. (Pubitemid 33116137)
    • (2001) Annals of Neurology , vol.50 , Issue.6 , pp. 773-779
    • Wang, M.S.1    Fang, G.2    Culver, D.G.3    Davis, A.A.4    Rich, M.M.5    Glass, J.D.6
  • 57
    • 23244436227 scopus 로고    scopus 로고
    • Axon retraction and degeneration in development and disease
    • DOI 10.1146/annurev.neuro.28.061604.135632
    • Luo L, O'Leary DD. Axon retraction and degeneration in development and disease. Annu Rev Neurosci 2005;28:127-156. (Pubitemid 41098902)
    • (2005) Annual Review of Neuroscience , vol.28 , pp. 127-156
    • Luo, L.1    O'Leary, D.D.M.2
  • 58
    • 1542380508 scopus 로고    scopus 로고
    • s-mediated protection of dopaminergic fibers in an animal model of Parkinson disease
    • DOI 10.1016/S0960-9822(04)00050-8, PII S0960982204000508
    • Sajadi A, Schneider BL, Aebischer P. Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol 2004;14:326-330. (Pubitemid 38300211)
    • (2004) Current Biology , vol.14 , Issue.4 , pp. 326-330
    • Sajadi, A.1    Schneider, B.L.2    Aebischer, P.3
  • 59
    • 33748432246 scopus 로고    scopus 로고
    • Wld(S) mice are protected against the Parkinsonian mimetic MPTP
    • Hasbani DM, O'Malley KL. Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 2006;202:93-99.
    • (2006) Exp Neurol , vol.202 , pp. 93-99
    • Hasbani, D.M.1    O'Malley, K.L.2
  • 60
    • 4043165678 scopus 로고    scopus 로고
    • Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
    • DOI 10.1126/science.1098014
    • Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004;305:1010-1013. (Pubitemid 39071777)
    • (2004) Science , vol.305 , Issue.5686 , pp. 1010-1013
    • Araki, T.1    Sasaki, Y.2    Milbrandt, J.3
  • 61
    • 33744926927 scopus 로고    scopus 로고
    • The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons
    • MacDonald JM, Beach MG, Porpiglia E, et al. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 2006;50:869-881.
    • (2006) Neuron , vol.50 , pp. 869-881
    • MacDonald, J.M.1    Beach, M.G.2    Porpiglia, E.3
  • 62
    • 61449113031 scopus 로고    scopus 로고
    • Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
    • Conforti L, Wilbrey A, Morreale G, et al. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 2009;184:491-500.
    • (2009) J Cell Biol , vol.184 , pp. 491-500
    • Conforti, L.1    Wilbrey, A.2    Morreale, G.3
  • 63
    • 65649126738 scopus 로고    scopus 로고
    • Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide
    • Sasaki Y, Vohra BP, Lund FE, et al. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci 2009;29:5525-5535.
    • (2009) J Neurosci , vol.29 , pp. 5525-5535
    • Sasaki, Y.1    Vohra, B.P.2    Lund, F.E.3
  • 64
    • 33748174151 scopus 로고    scopus 로고
    • Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
    • DOI 10.1523/JNEUROSCI.2320-06.2006
    • Sasaki Y, Araki T, Milbrandt J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J Neurosci 2006;26:8484-8491. (Pubitemid 44316176)
    • (2006) Journal of Neuroscience , vol.26 , Issue.33 , pp. 8484-8491
    • Sasaki, Y.1    Araki, T.2    Milbrandt, J.3
  • 65
    • 61449233205 scopus 로고    scopus 로고
    • Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration
    • Avery MA, Sheehan AE, Kerr KS, et al. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration. J Cell Biol 2009;184:501-513.
    • (2009) J Cell Biol , vol.184 , pp. 501-513
    • Avery, M.A.1    Sheehan, A.E.2    Kerr, K.S.3
  • 66
    • 66049102890 scopus 로고    scopus 로고
    • Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration
    • Yahata N, Yuasa S, Araki T. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci 2009;29:6276-6284.
    • (2009) J Neurosci , vol.29 , pp. 6276-6284
    • Yahata, N.1    Yuasa, S.2    Araki, T.3
  • 67
    • 0032440766 scopus 로고    scopus 로고
    • In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system
    • Srinivasan A, Roth KA, Sayers RO, et al. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 1998;5:1004-1016.
    • (1998) Cell Death Differ , vol.5 , pp. 1004-1016
    • Srinivasan, A.1    Roth, K.A.2    Sayers, R.O.3
  • 70
    • 0037037438 scopus 로고    scopus 로고
    • Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons
    • El-Khodor BF, Burke RE. Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J Comp Neurol 2002;452:65-79.
    • (2002) J Comp Neurol , vol.452 , pp. 65-79
    • El-Khodor, B.F.1    Burke, R.E.2
  • 71
    • 60549089207 scopus 로고    scopus 로고
    • APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
    • Nikolaev A, McLaughlin T, O'Leary DD, et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009;457:981-989.
    • (2009) Nature , vol.457 , pp. 981-989
    • Nikolaev, A.1    McLaughlin, T.2    O'Leary, D.D.3
  • 72
    • 28244466782 scopus 로고    scopus 로고
    • CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism
    • Silva RM, Ries V, Oo TF, et al. CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J Neurochem 2005;95:974-986.
    • (2005) J Neurochem , vol.95 , pp. 974-986
    • Silva, R.M.1    Ries, V.2    Oo, T.F.3
  • 73
    • 0028865136 scopus 로고
    • Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
    • Sagot Y, Dubois-Dauphin M, Tan SA, et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 1995;15:7727-7733.
    • (1995) J Neurosci , vol.15 , pp. 7727-7733
    • Sagot, Y.1    Dubois-Dauphin, M.2    Tan, S.A.3
  • 74
    • 22844445441 scopus 로고    scopus 로고
    • Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease
    • Silva RM, Kuan CY, Rakic P, et al. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease. Mov Disord 2005;20:653-664.
    • (2005) Mov Disord , vol.20 , pp. 653-664
    • Silva, R.M.1    Kuan, C.Y.2    Rakic, P.3
  • 75
    • 38449107680 scopus 로고    scopus 로고
    • Programmed cell death and new discoveries in the genetics of parkinsonism
    • Burke RE. Programmed cell death and new discoveries in the genetics of parkinsonism. J Neurochem 2008;104:875-890.
    • (2008) J Neurochem , vol.104 , pp. 875-890
    • Burke, R.E.1
  • 76
    • 35148882113 scopus 로고    scopus 로고
    • Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
    • The Parkinson Study Group PRECEPT Investigators
    • The Parkinson Study Group PRECEPT Investigators. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 2007;69:1480-1490.
    • (2007) Neurology , vol.69 , pp. 1480-1490
  • 77
    • 33750207744 scopus 로고    scopus 로고
    • Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases
    • Waldmeier P, Bozyczko-Coyne D, Williams M, Vaught JL. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases. Biochem Pharmacol 2006;72:1197-1206.
    • (2006) Biochem Pharmacol , vol.72 , pp. 1197-1206
    • Waldmeier, P.1    Bozyczko-Coyne, D.2    Williams, M.3    Vaught, J.L.4
  • 78
    • 77950680730 scopus 로고    scopus 로고
    • Akt/PKB inhibits retrograde axonal degeneration in the nigro-striatal dopaminergic pathway in vivo
    • Presentation 741.7
    • Cheng HC, Oo TF, Kareva T, et al. Akt/PKB inhibits retrograde axonal degeneration in the nigro-striatal dopaminergic pathway in vivo. Abstr Soc Neurosci 2008, Presentation 741.7.
    • (2008) Abstr Soc Neurosci
    • Cheng, H.C.1    Oo, T.F.2    Kareva, T.3
  • 79
    • 55849108858 scopus 로고    scopus 로고
    • Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway
    • Park KK, Liu K, Hu Y, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008;322:963-966.
    • (2008) Science , vol.322 , pp. 963-966
    • Park, K.K.1    Liu, K.2    Hu, Y.3
  • 80
    • 77952909073 scopus 로고    scopus 로고
    • Restoration of the nigro-striatal dopaminergic pathway in mouse models of Parkinson's disease: Effects of a constitutively active form of AKT
    • Presentation 247.19
    • Chen X, Kareva T, Rzhetskaya M, et al. Restoration of the nigro-striatal dopaminergic pathway in mouse models of Parkinson's disease: effects of a constitutively active form of AKT. Abstr Soc Neurosci 2008, Presentation 247.19.
    • (2008) Abstr Soc Neurosci
    • Chen, X.1    Kareva, T.2    Rzhetskaya, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.